Clinical Trials
2 trialsNCT02239731 2018-02-27
Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients
Vyne Therapeutics Inc.
Phase 2 Completed
NCT00803842 2015-02-26
Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash
Northwestern University
Phase NA Withdrawn